Schlosser Mario sold $532K of OSCR
Schlosser Mario sold 24,452 shares of Oscar Health, Inc. (OSCR) at $21.74 ($0.53M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider behavior but does not, by itself, indicate a new business development for OSCR.
Market read
Expect limited fundamental read-through; any short-term move is more likely sentiment/positioning than a catalyst.
What to watch
Traders may overreact to insider selling without checking whether it was pre-planned and whether other insiders/funds made offsetting moves around the same period.
Background
SEC Form 4 reports director/officer/10%-owner trades; Rule 10b5-1 indicates the trade was pre-arranged to mitigate insider-information concerns.
Ticker impact
Oscar Health director Mario Schlosser sold 24,452 shares in an open-market transaction worth ~$531.6K under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is more sentiment/flow-driven than fundamental.
The filing is a routine insider transaction and explicitly states a pre-arranged Rule 10b5-1 plan, reducing interpretability as a new negative view.
Market effects
Minimal; this is company-specific insider activity with no stated operational/regulatory catalyst.
None.
None.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish information; price impact may be overstated.
Key entities
- issuerOscar Health, Inc.
US-listed company whose director sold shares via open-market transaction under a 10b5-1 plan.
- insiderMario Schlosser
Director who executed the reported sale of OSCR shares.
